PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Al-Dabet, M.M.* ; Shahzad, K.* ; Elwakiel, A.* ; Sulaj, A.* ; Kopf, S.* ; Bock, F.* ; Gadi, I.* ; Zimmermann, S.* ; Rana, R.* ; Krishnan, S.* ; Gupta, D.* ; Manoharan, J.* ; Fatima, S.* ; Nazir, S.* ; Schwab, C.* ; Baber, R.* ; Scholz, M.* ; Geffers, R.* ; Mertens, P.R.* ; Nawroth, P.P.* ; Griffin, J.H.* ; Keller, M. ; Dockendorff, C.* ; Kohli, S.* ; Isermann, B.*

Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression.

Nat. Commun. 13:5062 (2022)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
A major obstacle in diabetes is the metabolic or hyperglycemic memory, which lacks specific therapies. Here we show that glucose-mediated changes in gene expression largely persist in diabetic kidney disease (DKD) despite reversing hyperglycemia. The senescence-associated cyclin-dependent kinase inhibitor p21 (Cdkn1a) was the top hit among genes persistently induced by hyperglycemia and was associated with induction of the p53-p21 pathway. Persistent p21 induction was confirmed in various animal models, human samples and in vitro models. Tubular and urinary p21-levels were associated with DKD severity and remained elevated despite improved blood glucose levels in humans. Mechanistically, sustained tubular p21 expression in DKD is linked to demethylation of its promoter and reduced DNMT1 expression. Two disease resolving agents, protease activated protein C (3K3A-aPC) and parmodulin-2, reversed sustained tubular p21 expression, tubular senescence, and DKD. Thus, p21-dependent tubular senescence is a pathway contributing to the hyperglycemic memory, which can be therapeutically targeted.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
17.694
3.341
2
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Journal Nature Communications
Quellenangaben Volume: 13, Issue: 1, Pages: , Article Number: 5062 Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Reviewing status Peer reviewed
Institute(s) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-506501-001
Grants Deutsche Forschungsgemeinschaft (German Research Foundation)
DOI 10.1038/s41467-022-32477-9
WOS ID WOS:000846449200001
Scopus ID 85136889572
PubMed ID 36030260
Erfassungsdatum 2022-11-15
[➜Report correction]